Crossject S.A. (ALCJ)
Euronext
Real-time Data
07:00 AM
Day's Range
1.3552 wk Range
1.35Overview - ALCJ - Crossject S.A.
Key Statistics
Valuation
Enterprise Value
91.89M
P/E (Forward)
‪2.71‬
PEG Ratio
‪2.71‬
Price / Sales (TTM)
‪32.95‬
EV / EBITDA
‪-8.62‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-629.28%‬
Return on Assets
‪-23.40%‬
Return on Equity
‪212.74%‬
Ownership
Shares Outstanding
52.18M
Float
51.16M
Held by Insiders
‪19.85%‬
Held by Institutions
‪0.40%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪1.63‬
200-Day Avg
‪1.98‬
Dividends
Payout Ratio
‪0.00%‬
Peers - ALCJ - Crossject S.A.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Euronext.
- ALCJEuronextCrossject S.A.84.63MMarket Cap-11.47%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ELEuronextEssilorLuxottica74.31BMarket Cap-66.48%52-week change30.24P/E (Trailing)‪8.51%‬Profit Margin
- DIMEuronextSartorius Stedim Biotech S.A.18.82BMarket Cap+9.64%52-week change64.50P/E (Trailing)‪9.73%‬Profit Margin
- COVEuronextCovivio5.70BMarket Cap-12.22%52-week change8.80P/E (Trailing)‪55.91%‬Profit Margin
- SOLVEuronextSolvac S.A.1.76BMarket Cap-13.70%52-week change14.08P/E (Trailing)‪3,324,813.70%‬Profit Margin
- NYXHEuronextNyxoah SA141.70MMarket Cap-301.84%52-week change-0.60P/E (Trailing)‪63.13%‬Profit Margin
- ALVMGEuronextVisiomed Group SA45.59MMarket Cap-37.42%52-week change51.67P/E (Trailing)‪45.95%‬Profit Margin
Profile Summary - ALCJ - Crossject S.A.
About
Crossject S.A. is a pharmaceutical company specializing in the development of needle-free, pre-filled delivery systems known as Zeneo injectors. Its primary function is to provide a pain-free, user-friendly alternative to traditional hypodermic injection methods, aiming to enhance patient compliance and accessibility.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
